09-19-2010, 10:16 AM
Hair loss or other side effects on cancer patients undergoing radiotherapy is set to become a thing of the past. A drug, which will reduce the side effects by 75% on cancer patients, will be soon out in the market.
Developed by Defence Research Development Organization (DRDO), 2-deoxy-D-glucose (2- DG) has completed three phases of clinical trials and has been recently sent to a Hyderabad-based laboratory for commercial production pending final approval from director general of health services.
Read more: Drug to cut cancer therapy side effects - The Times of India http://timesofindia.indiatimes.com/home/...z0zwdJnJFV
Developed by Defence Research Development Organization (DRDO), 2-deoxy-D-glucose (2- DG) has completed three phases of clinical trials and has been recently sent to a Hyderabad-based laboratory for commercial production pending final approval from director general of health services.
Read more: Drug to cut cancer therapy side effects - The Times of India http://timesofindia.indiatimes.com/home/...z0zwdJnJFV